# EDGAR Filing Document

**Accession Number:** 0000882291
**File Stem:** 0001683168-25-006350
**Filing Date:** 2025-8
**Character Count:** 2452
**Document Hash:** 68e42b838b5af00acda1b7976415bb29
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-25-006350.hdr.sgml**: 20250820

**ACCESSION NUMBER**: 0001683168-25-006350

**CONFORMED SUBMISSION TYPE**: 1-A-W

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250820

**DATE AS OF CHANGE**: 20250820

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AETHLON MEDICAL INC
- **CENTRAL INDEX KEY:** 0000882291
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 133632859
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 1-A-W
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 024-12551
- **FILM NUMBER:** 251237496

**BUSINESS ADDRESS:**
- **STREET 1:** 11555 SORRENTO VALLEY ROAD, SUITE 203
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** 619-941-0360

**MAIL ADDRESS:**
- **STREET 1:** 11555 SORRENTO VALLEY ROAD, SUITE 203
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BISHOP EQUITIES INC
- **DATE OF NAME CHANGE:** 19930602

**Aethlon Medical, Inc.**

**11555 Sorrento Valley Road, Suite 203**

**San Diego, CA 92121**

August 20, 2025

**VIA EDGAR**

Division of Corporation Finance

U.S. Securities & Exchange Commission (the "Commission")

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Aethlon Medical, Inc.** |
|  | **Offering Statement on Form 1-A** |
|  | **File No.** **024-12551** |

---

Ladies and Gentlemen:

In accordance with Rule 259 under the Securities Act of 1933, as amended, Aethlon Medical, Inc., a Delaware corporation (the "Company"), hereby respectfully requests the immediate withdrawal of its Offering Statement on Form 1-A (File. No. 024-12551), together with all exhibits and amendments thereto (collectively, the "Offering Statement"), which originally was filed with the Securities and Exchange Commission (the "Commission") on December 27, 2024.

The Company is requesting the consent of the Commission to the withdrawal of the Offering Statement as the Company has decided not to pursue the offering due to market conditions. The Offering Statement has not been declared qualified by the Commission, and no securities have been sold thereunder.

---

| |
|:---|
| Sincerely, |
| **AETHLON MEDICAL, INC.** |
| /s/ James Frakes |
| James Frakes |
| Chief Executive Officer |

---